Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Promethera Biosciences
223
Promethera Biosciences
Technology
Biotechnology
Health Care
Medical
Therapeutics
Promethera Biosciences is a biopharmaceutical company focused on cell therapyproducts to treat liver diseases.
Suggest edits
Founded
2009
Raised
$92.9M
Follow us
Companies in the same industry
Kyn Therapeutics
Stoke Therapeutics
Skyhawk Therapeutics
AC Immune
ArGEN-X
CoDa Therapeutics, Inc.
Hengrui Therapeutics, Inc.
3-V Biosciences
NextStep Robotics
Nimble Therapeutics
Alexa global traffic share
Overview
Funding
5
Add info
Latest funding
Show all
€9,300,000
Debt financing - 2018
Shinsei Corporate Investment Limited
Shibuya Corporation
€10,000,000
Venture capital (Series C) - 2016
Mitsui & Co. Global Investment
Mitsubishi UFJ Capital
Boehringer Ingelheim Venture Fund
+4
Team Size
10+
Employees
I work here
Location
Belgium
Headquarters
Explore Belgium
€9,300,000
Debt financing
FinSMEs
Promethera Biosciences Raises Additional €9.3M in Funding
Health
Science
€10,000,000
Venture capital (Series C)
businesswire
Promethera Biosciences Raises EUR 10 Million in a Series C-extension Financing to Advance its Broad Product Pipeline in...
